Advertisement

Loading...

VITA 34 AG

VTIAFPNK
Healthcare
Medical - Care Facilities
$6.38
$0.00(0.00%)
U.S. Market is Open • 10:11

VITA 34 AG Fundamental Analysis

VITA 34 AG (VTIAF) shows moderate financial fundamentals with a PE ratio of -9.43, profit margin of -11.17%, and ROE of -71.32%. The company generates $0.1B in annual revenue with moderate year-over-year growth of 6.65%.

Key Strengths

Cash Position12.16%
PEG Ratio-7.62

Areas of Concern

ROE-71.32%
Operating Margin-7.83%
Current Ratio0.68
We analyze VTIAF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -63.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-63.7/100

We analyze VTIAF's fundamental strength across five key dimensions:

Efficiency Score

Weak

VTIAF struggles to generate sufficient returns from assets.

ROA > 10%
-6.18%

Valuation Score

Excellent

VTIAF trades at attractive valuation levels.

PE < 25
-9.43
PEG Ratio < 2
-7.62

Growth Score

Moderate

VTIAF shows steady but slowing expansion.

Revenue Growth > 5%
6.65%
EPS Growth > 10%
-4.83%

Financial Health Score

Weak

VTIAF carries high financial risk with limited liquidity.

Debt/Equity < 1
1.41
Current Ratio > 1
0.68

Profitability Score

Weak

VTIAF struggles to sustain strong margins.

ROE > 15%
-7131.88%
Net Margin ≥ 15%
-11.17%
Positive Free Cash Flow
No

Key Financial Metrics

Is VTIAF Expensive or Cheap?

P/E Ratio

VTIAF trades at -9.43 times earnings. This suggests potential undervaluation.

-9.43

PEG Ratio

When adjusting for growth, VTIAF's PEG of -7.62 indicates potential undervaluation.

-7.62

Price to Book

The market values VITA 34 AG at 6.76 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.76

EV/EBITDA

Enterprise value stands at 30.48 times EBITDA. This signals the market has high growth expectations.

30.48

How Well Does VTIAF Make Money?

Net Profit Margin

For every $100 in sales, VITA 34 AG keeps $-11.17 as profit after all expenses.

-11.17%

Operating Margin

Core operations generate -7.83 in profit for every $100 in revenue, before interest and taxes.

-7.83%

ROE

Management delivers $-71.32 in profit for every $100 of shareholder equity.

-71.32%

ROA

VITA 34 AG generates $-6.18 in profit for every $100 in assets, demonstrating efficient asset deployment.

-6.18%

Following the Money - Real Cash Generation

Operating Cash Flow

VITA 34 AG generates limited operating cash flow of $4.44M, signaling weaker underlying cash strength.

$4.44M

Free Cash Flow

VITA 34 AG generates weak or negative free cash flow of $-399.50K, restricting financial flexibility.

$-399.50K

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

VTIAF converts -0.40% of its market value into free cash.

-0.40%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-9.43

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-7.62

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.76

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.09

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.41

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.68

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.71

vs 25 benchmark

ROA

Return on assets percentage

-0.06

vs 25 benchmark

ROCE

Return on capital employed

-0.07

vs 25 benchmark

How VTIAF Stacks Against Its Sector Peers

MetricVTIAF ValueSector AveragePerformance
P/E Ratio-9.4327.91 Better (Cheaper)
ROE-71.32%687.00% Weak
Net Margin-11.17%-45285.00% (disorted) Weak
Debt/Equity1.410.33 Weak (High Leverage)
Current Ratio0.682795.76 Weak Liquidity
ROA-6.18%-13557.00% (disorted) Weak

VTIAF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews VITA 34 AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-4.57%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-311.34%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-67.79%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ